Items where authors include "Shotton, R."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Wysocki, O. orcid.org/0000-0002-7053-4919, Zhou, C. orcid.org/0000-0002-6938-4685, Rogado, J. orcid.org/0000-0002-9795-8762 et al. (71 more authors) (2022) An international comparison of presentation, outcomes and CORONET predictive score performance in patients with cancer presenting with COVID-19 across different pandemic waves. Cancers, 14 (16). 3931. ISSN 2072-6694
Lee, R.J., Wysocki, O., Bhogal, T. et al. (37 more authors) (2021) Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome. ESMO Open, 6 (1). 100005. ISSN 2059-7029
Proceedings Paper
Summerton, S., Tivey, A., Shotton, R. et al. (5 more authors) (2023) Outlier detection of vital sign trajectories from COVID-19 patients. In: Proceedings of 2023 45th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC). 2023 45th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), 24-27 Jul 2023, Sydney, Australia. Institute of Electrical and Electronics Engineers (IEEE) . ISBN 979-8-3503-2447-1